GLP-1s drive a historic shift in traditional drug spending increases, outpacing specialty drug trends for the first time.

The presentation included new PK and PD data showing that 90mg of avexitide daily maintained continuous pharmacologic ...

CoQ10 may interact with certain medications, causing side effects or making them less effective. Find out if you shouldn't ...

The Europe GLP-1 agonists market, valued at USD 7.09 billion in 2024, is set to grow at a 17.30% CAGR, reaching USD 14.34 billion by 2034. Driven by ...

Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18 ...

Key Takeaways Menopause hormone therapy appears to boost the effectiveness of tirzepatide (Zepbound)Women lost more weight ...

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side effect of weight loss drugs.

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

Regarding injection site rotation, alternate between different areas like the abdomen, thigh, or upper arm to prevent ...

Scientists have gene-hacked mice to produce their own Ozempic-like drugs, paving a path for humans to do so themselves one ...

A national survey found low use of weight loss drugs for MASLD despite widespread belief in their benefits. A study published in June 2025 issue of Journal of Clinical Gastroenterology highlighted the ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...